Mayra

Dienogest/Ethinylestradiol, the active ingredient in Mayra, is a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Mayra as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mayra is a combined hormonal contraceptive that acts on the reproductive hormone pathway to prevent pregnancy and manage menstrual disorders. - Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Regulation of menstrual cycles: reduces irregular bleeding and provides predictable cycle control. - Management of dysmenorrhea: alleviates painful menstrual cramps through hormonal stabilization.

Mayra may cause a range of adverse reactions. Most are mild and transient, but rare serious events can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: swelling or discomfort. - Weight gain: modest increase in body weight. - Mood changes: irritability or mood swings. - Spotting: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: clot formation in arteries. - Hypertension: elevated blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Severe allergic reactions: rash, swelling, anaphylaxis. - Gallbladder disease: inflammation or stones.

Before prescribing Mayra, clinicians should evaluate patient history and risk factors. - Assess medical history: identify thrombosis, cardiovascular, or liver disease. - Avoid smoking: especially in women over 35 years of age. - Monitor blood pressure: hypertension may develop during therapy. - Review medication list: potential interactions can affect efficacy. - Consider liver function: contraindicated in severe hepatic impairment. - Store at ambient temperature: keep below 25°C, protect from moisture.

Mayra can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Anticoagulants (warfarin): may reduce anticoagulant effect. - Antiepileptics (carbamazepine, phenytoin): increase hormone metabolism, lowering contraceptive efficacy. - Rifampicin and other strong enzyme inducers: may cause contraceptive failure.

Moderate Interactions (Monitor Closely): - Antibiotics (tetracycline, penicillins): may slightly reduce hormonal effect. - SSRIs (fluoxetine, sertraline): can increase hormone levels. - Herbal supplements (St. John's wort, ginseng): possible enzyme induction affecting efficacy.